Verve Therapeutics, Inc. (VERV) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Verve Therapeutics, Inc., with annual and quarterly history.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -2.40x | -4.47x | -6.64x | -15.08x | -33.79x | -48.96x |
| P/B Ratio | 0.97x | 1.49x | 1.90x | 5.01x | -24.08x | -47.63x |
| P/S Ratio | 14.78x | 76.08x | 538.57x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 100.0% | 100.0% | 100.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | -707.2% | -1897.6% | -8536.2% | 0.0% | 0.0% | 0.0% |
| Net Margin | -614.6% | -1701.5% | -8108.6% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | -686.3% | -1851.2% | -8391.7% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 12.65x | 17.24x | 16.05x | 16.67x | 10.11x | 5.36x |
| Quick Ratio | 12.65x | 17.24x | 16.05x | 16.67x | 10.11x | 5.36x |
| Leverage | ||||||
| Debt/Equity | 0.14x | 0.12x | 0.15x | 0.01x | -1.96x | -1.79x |
YoY = year-over-year change. Source: FMP..